Create Alert
Watchlist

Caplin Point Laboratories

₹2,214.80
-46.30 (2.05%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
2,259.90
Prev. Close
2,261.10
Volume
27,086
Total traded value
6.00 Cr
Upper Circuit
2,713.30
Lower Circuit
1,808.90

Fundamentals

Market Cap₹17,195Cr
ROE18.81%
P/E Ratio(TTM)30.43
EPS(TTM)74.35
P/B Ratio6.03
Dividend Yield0.24%
Industry P/E35.19
Book Value375.01
Debt to Equity0.00
Face Value2
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Caplin Point Labs

Caplin Point is a fast-growing pharmaceutical company from India, developing and marketing a wide range of generic and branded medicines globally. Its core business model involves serving less competitive, unconventional markets and managing its entire supply chain from production to last-mile distribution. This strategy has enabled the company to establish over 30,000 distribution touch points in the Latin American market alone.;
Parent OrganisationCaplin Point Laboratories Limited
Managing DirectorDr. Sridhar Ganesan
NSE SymbolCAPLIPOINT

Shareholding Pattern

Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Promoters
70.56%
Retail And Others
21.05%
Foreign Institutions
6.17%
Mutual Funds
1.93%
Other Domestic Institutions
0.29%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Torrent Pharmaceuticals
NA
(0.00%)
61.10
Gland Pharma
NA
(0.00%)
42.27
Ajanta Pharma
NA
(0.00%)
33.99
Eris Lifesciences
NA
(0.00%)
57.15